COMBINATION OF IFN-GAMMA WITH ANTI-ERBB ANTIBODY FOR THE TREATMENT OF CANCERS

摘要

Chimeric molecules comprising an anti-p185her2/neu or anti-EGFR polypeptide, a second polypeptide that binds to at least one other polypeptide other than p185her2/neu or EGFR, and a third polypeptide encoding a biologically active portion of interferon gamma are provided. The chimeric molecule compositions can be administered to treat or prevent cancer.